152 related articles for article (PubMed ID: 17390103)
1. The effects of lorazepam on skin conductance responses to aversive stimuli in healthy subjects.
Siepmann M; Heine B; Kluge A; Ziemssen T; Mück-Weymann M; Kirch W
Clin Auton Res; 2007 Jun; 17(3):160-4. PubMed ID: 17390103
[TBL] [Abstract][Full Text] [Related]
2. Effects of lorazepam on fear-potentiated startle responses in man.
Graham SJ; Scaife JC; Langley RW; Bradshaw CM; Szabadi E; Xi L; Crumley T; Calder N; Gottesdiener K; Wagner JA
J Psychopharmacol; 2005 May; 19(3):249-58. PubMed ID: 15888510
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive indices of autonomic regulation after alprazolam and lorazepam: effects on sympathovagal balance.
Tulen JH; Man in't Veld AJ
J Cardiovasc Pharmacol; 1998 Aug; 32(2):183-90. PubMed ID: 9700978
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
Grünberger J; Saletu B; Linzmayer L; Böck G; Weissgram S; Brandstaätter N; Frey R; Saletu-Zyhlarz G
Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
[TBL] [Abstract][Full Text] [Related]
5. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.
Paulus MP; Feinstein JS; Castillo G; Simmons AN; Stein MB
Arch Gen Psychiatry; 2005 Mar; 62(3):282-8. PubMed ID: 15753241
[TBL] [Abstract][Full Text] [Related]
7. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam.
Brignell CM; Rosenthal J; Curran HV
J Psychopharmacol; 2007 Sep; 21(7):673-83. PubMed ID: 17606475
[TBL] [Abstract][Full Text] [Related]
9. The effects of clonidine on the fear-inhibited light reflex.
Bitsios P; Szabadi E; Bradshaw CM
J Psychopharmacol; 1998; 12(2):137-45. PubMed ID: 9694025
[TBL] [Abstract][Full Text] [Related]
10. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
Lister RG; File SE
J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
[TBL] [Abstract][Full Text] [Related]
11. Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans.
Hellewell JS; Guimaraes FS; Wang M; Deakin JF
J Psychopharmacol; 1999; 13(2):122-7. PubMed ID: 10475716
[TBL] [Abstract][Full Text] [Related]
12. Effects of lorazepam on film-induced differentiated emotions in healthy volunteers.
Garcia C; Philippot P; Lacarelle B; Valli M; Rimé B; Bruguerolle B; Blin O
Fundam Clin Pharmacol; 1997; 11(5):466-75. PubMed ID: 9342601
[TBL] [Abstract][Full Text] [Related]
13. Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers.
Ferrara SD; Giorgetti R; Zancaner S; Orlando R; Tagliabracci A; Cavarzeran F; Palatini P
Eur J Clin Pharmacol; 1999 Jan; 54(11):821-7. PubMed ID: 10027654
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
[TBL] [Abstract][Full Text] [Related]
16. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
[TBL] [Abstract][Full Text] [Related]
18. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Morton S; Lader M
Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
[TBL] [Abstract][Full Text] [Related]
19. Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.
Schunck T; Mathis A; Erb G; Namer IJ; Demazières A; Luthringer R
J Psychopharmacol; 2010 May; 24(5):701-8. PubMed ID: 19460871
[TBL] [Abstract][Full Text] [Related]
20. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
Curran HV; Schifano F; Lader M
Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
